| Glycine, serine and threonine metabolism |    |
| Caffeine Metabolism |    |
| Dihydropyrimidine Dehydrogenase Deficiency (DHPD) |    |
| Non Ketotic Hyperglycinemia |    |
| Dimethylglycine Dehydrogenase Deficiency |    |
| Sarcosinemia |    |
| Lidocaine (Antiarrhythmic) Action Pathway |    |
| Lidocaine (Local Anaesthetic) Action Pathway |    |
| Codeine Action Pathway |    |
| Methadone Action Pathway |    |
| Imipramine Action Pathway |    |
| Citalopram Action Pathway |    |
| Fluoxetine Action Pathway |    |
| Nicotine Action Pathway |    |
| Etoposide Action Pathway |    |
| Teniposide Action Pathway |    |
| Tamoxifen Action Pathway |    |
| Dimethylglycine Dehydrogenase Deficiency |    |
| Hyperglycinemia, non-ketotic |    |
| Etoposide Metabolism Pathway |    |
| Teniposide Metabolism Pathway |    |
| Tamoxifen Metabolism Pathway |    |
| Lidocaine (Local Anaesthetic) Metabolism Pathway |    |
| Codeine Metabolism Pathway |    |
| Methadone Metabolism Pathway |    |
| Imipramine Metabolism Pathway |    |
| Citalopram Metabolism Pathway |    |
| Nicotine Metabolism Pathway |    |
| Venlafaxine Metabolism Pathway |    |
| Tramadol Metabolism Pathway |    |
| Levomethadyl Acetate Metabolism Pathway |    |
| Clomipramine Metabolism Pathway |    |
| Doxepin Metabolism Pathway |    |
| Fluoxetine Metabolism Pathway |    |
| Artemether Metabolism Pathway |    |
| Mycophenolic Acid Metabolism Pathway |    |
| Rosiglitazone Metabolism Pathway |    |
| 3-Phosphoglycerate dehydrogenase deficiency |    |
